The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Open accessAbstract
The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside. Clinical Pharmacology & Therapeutics (2011) 89 3, 464–467. doi:10.1038/clpt.2010.279
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Relling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C.-H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.320 · Cited by 574
Self-citationTranslation of pharmacogenomics and pharmacogenetics: a regulatory perspective
Lesko, L. J., & Woodcock, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1499 · Cited by 200
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype
Altman, R. B. (2007) · Nature Genetics · doi:10.1038/ng0407-426 · Cited by 124
Nunnelee, J. D. (2009) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2009.09.001 · Cited by 111
Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence
Petitti, D. B., Teutsch, S. M., Barton, M. B., Sawaya, G. F., Ockene, J. K., DeWitt, T., & on behalf of the U.S. Preventive Services Task Force (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-3-200902030-00010 · Cited by 101
Deverka, P. A., Doksum, T., & Carlson, R. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100319 · Cited by 52
Cited by
The “All of Us” Research Program
The All of Us Research Program Investigators (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1809937 · Cited by 2,440
Pharmacogenomics Knowledge for Personalized Medicine
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.96 · Cited by 1,796
Self-citationScott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.105 · Cited by 962
Self-citationPharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Self-citationThe “All of Us” Research Program
(2019) · New England Journal of Medicine · doi:10.1056/nejmc1912496 · Cited by 843
An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Whirl‐Carrillo, M., Huddart, R., Gong, L., Sangkuhl, K., Thorn, C. F., Whaley, R., & Klein, T. E. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2350 · Cited by 810
Self-citationJohnson, J., Caudle, K., Gong, L., Whirl‐Carrillo, M., Stein, C., Scott, S., Lee, M., Gage, B., Kimmel, S., Perera, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.668 · Cited by 716
Self-citationAmstutz, U., Henricks, L. M., Offer, S. M., Barbarino, J., Schellens, J. H. M., Swen, J. J., Klein, T. E., McLeod, H. L., Caudle, K. E., Diasio, R. B., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.911 · Cited by 694
Self-citationJohnson, J. A., Gong, L., Whirl-Carrillo, M., Gage, B. F., Scott, S. A., Stein, C. M., Anderson, J. L., Kimmel, S. E., Lee, M. T. M., Pirmohamed, M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.185 · Cited by 647
Self-citationRelling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C.-H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.320 · Cited by 574
Self-citationImplementing genomic medicine in the clinic: the future is here
Manolio, T. A., Chisholm, R. L., Ozenberger, B., Roden, D. M., Williams, M. S., Wilson, R., Bick, D., Bottinger, E. P., Brilliant, M. H., Eng, C., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.157 · Cited by 566
Self-citationPreemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citationPrediction of CYP2D6 phenotype from genotype across world populations
Gaedigk, A., Sangkuhl, K., Whirl-Carrillo, M., Klein, T., & Leeder, J. S. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.80 · Cited by 506
Self-citationScott, S. A., Sangkuhl, K., Gardner, E. E., Stein, C. M., Hulot, J.-S., Johnson, J. A., Roden, D. M., Klein, T. E., & Shuldiner, A. R. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.132 · Cited by 484
Self-citationHicks, J. K., Swen, J. J., Thorn, C. F., Sangkuhl, K., Kharasch, E. D., Ellingrod, V. L., Skaar, T. C., Müller, D. J., Gaedigk, A., & Stingl, J. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.2 · Cited by 453
Caudle, K., Klein, T., Hoffman, J., Muller, D., Whirl-Carrillo, M., Gong, L., McDonagh, E., Sangkuhl, K., Thorn, C., Schwab, M., et al. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140130124910 · Cited by 446
Self-citationRoden, D. M., McLeod, H. L., Relling, M. V., Williams, M. S., Mensah, G. A., Peterson, J. F., & Van Driest, S. L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31276-0 · Cited by 427
Self-citationVariant interpretation: functional assays to the rescue
Starita, L. M., Ahituv, N., Dunham, M. J., Kitzman, J. O., Roth, F. P., Seelig, G., Shendure, J., & Fowler, D. M. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.014 · Cited by 381
PharmGKB: The Pharmacogenomics Knowledge Base
Thorn, C. F., Klein, T. E., & Altman, R. B. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-435-7_20 · Cited by 358
Self-citationPharmGKB: A worldwide resource for pharmacogenomic information
Barbarino, J. M., Whirl‐Carrillo, M., Altman, R. B., & Klein, T. E. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1417 · Cited by 358
Self-citationThe Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
Relling, M. V., Klein, T. E., Gammal, R. S., Whirl‐Carrillo, M., Hoffman, J. M., & Caudle, K. E. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1651 · Cited by 358
Self-citationWilke, R. A., Ramsey, L. B., Johnson, S. G., Maxwell, W. D., McLeod, H. L., Voora, D., Krauss, R. M., Roden, D. M., Feng, Q., Cooper-DeHoff, R. M., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.57 · Cited by 332
Self-citationCaudle, K. E., Thorn, C. F., Klein, T. E., Swen, J. J., McLeod, H. L., Diasio, R. B., & Schwab, M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.172 · Cited by 330
Self-citationRelling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C.-H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., Hicks, J. K., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.4 · Cited by 329
Self-citationvan der Wouden, C., Cambon‐Thomsen, A., Cecchin, E., Cheung, K., Dávila‐Fajardo, C., Deneer, V., Dolžan, V, Ingelman‐Sundberg, M., Jönsson, S., Karlsson, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.602 · Cited by 306
Bielinski, S. J., Olson, J. E., Pathak, J., Weinshilboum, R. M., Wang, L., Lyke, K. J., Ryu, E., Targonski, P. V., Van Norstrand, M. D., Hathcock, M. A., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.10.021 · Cited by 301
Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
Preissner, S. C., Hoffmann, M. F., Preissner, R., Dunkel, M., Gewiess, A., & Preissner, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082562 · Cited by 278
PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
Hoffman, J. M., Haidar, C. E., Wilkinson, M. R., Crews, K. R., Baker, D. K., Kornegay, N. M., Yang, W., Pui, C., Reiss, U. M., Gaur, A. H., et al. (2014) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31391 · Cited by 276
Self-citationProton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine
El Rouby, N., Lima, J. J., & Johnson, J. A. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1461835 · Cited by 263
Owusu Obeng, A., Fei, K., Levy, K. D., Elsey, A. R., Pollin, T. I., Ramirez, A. H., Weitzel, K. W., & Horowitz, C. R. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8030024 · Cited by 131
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Menke, A. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s146110 · Cited by 41
“116,117 Genetic variants within these genes have been repeatedly associated with patients’ metabolizer phenotype118,119 and subsequently have been included in dosing guidelines for antidepressants by expert groups such as the Clinical Pharmacogenetics Implementation Consortium.120 Genetic variants within CYP2D6 and CY…”
The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine
Schwartz, E. J., & Issa, A. M. (2017) · Personalized Medicine · doi:10.2217/pme-2016-0063 · Cited by 29
Polypharmacy and precision medicine
Fujita, K., Masnoon, N., Mach, J., O’Donnell, L. K., & Hilmer, S. N. (2023) · Cambridge Prisms: Precision Medicine · doi:10.1017/pcm.2023.10 · Cited by 27
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23
Nguyen, T. T., Leary, E. J. W., Lee, J. T., Shukla, S. K., & Griesbach, S. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1500235 · Cited by 7
Metadata
- Authors
- Relling, M. V., & Klein, T. E.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-01-26
- Volume
- 89
- Issue
- 3
- Pages
- 464-467
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1969692023
- Cited by
- 1,164
- References
- 7
- FWCI
- 62.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.